Nova Eye Medical Limited (ASX:EYE)

Nova Eye Medical Revenue

In the fiscal year ending June 30, 2026, Nova Eye Medical had annual revenue of 34.87M AUD with 19.13% growth. Nova Eye Medical had revenue of 18.15M in the half year ending June 30, 2026, with 37.67% growth. That makes Nova Eye Medical the 32,604th largest company in the world by revenue and 566th in Australia.

• Revenue: 34.87M
• Revenue Growth: +19.13%
• P/S Ratio: 1.31
• Revenue / Employee: 115.83K
• Employees: 301
• Market Cap: 45.59M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Glaucoma Surgical Devices 29.08M 99.4%
• AlphaRET 190.00K 0.6%

By Geography

Chart

• United States of America 22.88M 78.2%
• Europe 3.89M 13.3%
• Asia Pacific 1.96M 6.7%
• Other 507.00K 1.7%
• Australia 35.00K 0.1%

Fiscal year ended Jun 30, 2025 See the full Nova Eye Medical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	34.87M	5.60M	19.13%
Jun 30, 2025	29.27M	5.94M	25.47%
Jun 30, 2024	23.33M	6.30M	37.00%
Jun 30, 2023	17.03M	3.65M	27.26%
Jun 30, 2022	13.38M	-16.00K	-0.12%

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 26, 2026

Data Sources Report a data error